X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…
NEXTEER’S FACILITY GRAND OPENING IN CHANGSHU, CHINA EXPANDS ADVANCED STEERING PRODUCTION & VALIDATION
Capitalizes on Company's APAC Growth Momentum CHANGSHU, China, Jan. 15, 2025 /PRNewswire/…
NEXTEER’S FACILITY GRAND OPENING IN CHANGSHU, CHINA EXPANDS ADVANCED STEERING PRODUCTION & VALIDATION
Capitalizes on Company's APAC Growth Momentum CHANGSHU, China, Jan. 15, 2025 /PRNewswire/…
Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation
LIMERICK, Ireland, Jan. 09, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI)…
Beko Secures Science Based Targets initiative (SBTi) Validation for 1.5C Aligned Near-Term and Net-Zero Targets
Beko's 1.5°C aligned near-term and net-zero targets are approved by Science Based…
CarbonChain has received third-party validation for its latest Corporate Carbon Footprint Accounting and Reporting Methodology and Product Carbon Footprint Accounting and Reporting Methodology
- and additional sector-specific methodologies for oil & gas, transport, and metals…